Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06376032 · ClinicalTrials.gov registry record · NA

EndeavorOTC® Research Study in College Students

A NA study of Cognition and Attention, sponsored by Akili Interactive Labs.

Active
Registry status
NA
Development phase
69
Enrollment target
2
Study locations

NCT06376032 is a NA study of Cognition and Attention that is active but no longer recruiting, run by Akili Interactive Labs. The registered enrollment target is 69 participants, below the 170-participant average among 35 other Cognition trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06376032, a NA study of Cognition and Attention, is active but no longer recruiting, sponsored by Akili Interactive Labs.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
69 participants
Enrollment target
2
Study locations

Study Summary

The objective of this study is to evaluate the impact of a digital therapeutic (EndeavorOTC®, also known as AKL-T01A) on clinical symptoms of executive and cognitive functioning in a real-world sample of university students. This study aims to answer whether EndeavorOTC represents a useful intervention for targeting broad cognitive and emotional health among university students.

Conditions Studied

Cognition Attention University Students

Interventions

  • DEVICE EndeavorOTC®

Study Locations (2)

New York

  • Villa Maria College - Cheektowaga

Vermont

  • Landmark College - Putney

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2024-01-10
Est. Completion 2025-12-31
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06376032

The ClinicalTrials.gov registry entry for NCT06376032 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 35 other Cognition trials with a reported enrollment target (59% lower). The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cognition appearing as the primary indexed condition, and to 1 intervention - of which EndeavorOTC® is the first listed.

NCT06376032 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Vermont.

Frequently Asked Questions

What is clinical trial NCT06376032 about?

NCT06376032 is a clinical study titled "EndeavorOTC® Research Study in College Students". The objective of this study is to evaluate the impact of a digital therapeutic (EndeavorOTC®, also known as AKL-T01A) on clinical symptoms of executive and cognitive functioning in a real-world sample of university students. This study aims to answer whether EndeavorOTC represents a useful intervent...

What is the current status of trial NCT06376032?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 69 participants. The study started on 2024-01-10. Estimated completion is 2025-12-31.

What conditions does trial NCT06376032 study?

This clinical trial studies the following conditions: Cognition, Attention, University Students.

What interventions are being tested in trial NCT06376032?

The interventions under investigation include: EndeavorOTC® (DEVICE).

Who is sponsoring clinical trial NCT06376032?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06376032 being conducted?

This trial has 2 study locations across New York, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cognition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cognition

All registered trials for this condition

Attention

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.